Maternal serum activin A, inhibin A, and follistatin in pregnancies with appropriately grown and small-for-gestational-age fetuses classified by umbilical artery Doppler ultrasound

American Journal of Obstetrics and Gynecology

Volumn 186, Issue 2, 2002, Pages 283-287

  McGrath, Shaun ^a   McLean, Mark ^c   Smith, David ^b   Bisits, Andrew ^a   Giles, Warwick ^a   Smith, Roger ^a  

^a JOHN HUNTER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Activin A; Doppler imaging; Follistatin; Inhibin A; Small for gestational age

Indexed keywords

ACTIVIN A; FOLLISTATIN; INHIBIN A;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DOPPLER FLOWMETRY; FEMALE; FETUS; FETUS GROWTH; HORMONE BLOOD LEVEL; HORMONE DETERMINATION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MATERNAL SERUM; NEWBORN; PLACENTA FUNCTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SMALL FOR DATE INFANT; UMBILICAL ARTERY;

EID: 0036176717     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2002.119777     Document Type: Article

References (24)

1. Small for gestational age is not a diagnosis
2. Fetal and neonatal mortality in the postterm pregnancy: The impact of gestational age and fetal growth restriction
3. Fetal oxygenation at cordocentesis, maternal smoking and childhood neurodevelopment
4. Fetal growth velocity: A cautionary tale
5. Nutrients, growth, and the development of programmed metabolic function
6. A prospective study of maternal serum insulin-like growth factor-I in pregnancies with appropriately grown or growth restricted fetuses
7. Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth
8. Detection of dimeric inhibin throughout the human menstrual cycle by two-site enzyme immunoassay
9. Serum concentrations of dimeric inhibin during the spontaneous human menstrual cycle and after treatment with exogenous gonadotrophin
10. Development and application of a two-site enzyme immunoassay for the determination of 'total' activin-A concentrations in serum and follicular fluid
11. Development, validation and application of an ultra-sensitive two-site enzyme immunoassay for human follistatin
12. Source of circulating levels of inhibin A, pro alpha C-containing inhibins and activin A in early pregnancy
13. Measurement of serum concentrations of inhibin-A (alpha-beta A dimer) during human pregnancy
14. Changes in peripheral serum levels of total activin A during the human menstrual cycle and pregnancy
15. A longitudinal study of maternal serum inhibin-A, inhibin-B, activin-A, activin-AB, pro-alphaC and follistatin during pregnancy
16. Serum activin A and follistatin concentrations during human pregnancy: A cross-sectional and longitudinal study
17. Activin A and inhibin A as possible endocrine markers for pre-eclampsia
18. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia
19. Abnormal concentration of maternal serum activin-A in gestational diseases
20. Increased maternal serum activin A but not follistatin levels in pregnant women with hypertensive disorders
21. Follistatin activin complexes in human serum and follicular fluid differ immunologically and biochemically
22. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
23. A study of placental bed spiral arteries and trophoblast invasion in normal and severe pre-eclamptic pregnancies